Patanjali CEO, Acharya Balkrishna, in an interview with news agency ANI has denied claiming that their drug Coronil can cure or control COVID-19.
Acharya Balkrishna, Patanjali CEO denied claiming that their drug Coronil can cure or control COVID-19. The head of the company said this during an interview with news agency ANI.
"We never said the medicine (Coronil) can cure or control corona. We said that we had made medicines and used them in clinical controlled trial which cured corona patients. There is no confusion in it," Acharya Balkrishna said.
The statement has come at a time when an FIR was filed in Jaipur against yoga guru Baba Ramdev, Patanjali CEO Acharya Balkrishna and four others for "misleading" people by propagating Patanjali Ayurved's drug Coronil as a cure for the infection.
At the Coronil launch, the company had claimed that its medicine can cure the contagious disease within seven days.
It said Coronil, taken along with another product developed by it, had shown a 100% success rate in clinical trials on infected patients, except those on life support.
Ramdev said the medicines were developed by Patanjali Research Centre, Haridwar in association with privately-owned NIMS, Jaipur.
According to reports, the Rajasthan's health department has served a notice to NIMS hospital in Jaipur seeking an explanation on conducting trials of Patanjali Ayurved's drug Coronil on coronavirus patients.
Last Updated 30, Jun 2020, 6:04 PM